{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T21:02:35Z","timestamp":1763067755890,"version":"3.45.0"},"reference-count":25,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Esophageal squamous cell carcinoma (ESCC) is a prevalent cancer in eastern Africa. Optimal management strategies in eastern Africa have not been well established. This study aimed to evaluate ESCC treatment outcomes at Kamuzu Central Hospital (KCH), a national cancer center in Malawi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      This prospective, observational, cohort study was conducted as part of a multicenter collaboration within the African Esophageal Cancer Consortium (ClinicalTrials.gov identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05177393\">NCT05177393<\/jats:ext-link>\n                      ). Patients who presented to KCH with esophageal cancer (EC) were recruited from June 2021 to December 2022. Data on patient and treatment characteristics were collected using interviews and chart review. Mobile phone outreach was used to assess patient-reported outcomes (PROs). PROs were analyzed using linear mixed modeling. Kaplan-Meier method with log-rank test and Cox proportional hazards regression were used to evaluate overall survival by treatment group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      A total of 148 of 150 eligible patients enrolled. Of 114 with biopsy-proven EC, 97% (n = 111) had ESCC. Most were documented as having localized disease; however, 56% did not complete staging imaging. Forty-seven percent received supportive care, 30% self-expandable metallic stent (SEMS), 20% chemotherapy, and 3% SEMS plus chemotherapy. SEMS was associated with the highest proportion experiencing dysphagia improvement (SEMS 68%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      chemotherapy 63%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      supportive care 39%). Twelve-month survival rate was the highest in the chemotherapy arm (29%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      supportive care 19%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      SEMS 6%, log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .018).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>ESCC remains a highly fatal malignancy in Malawi. Most patients at KCH are treated with SEMS or supportive care. Although data must be interpreted with caution given likely confounding, chemotherapy was associated with the highest 12-month survival rate as compared with SEMS and supportive care, whereas SEMS was associated with the highest likelihood of improved dysphagia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00221","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T20:59:13Z","timestamp":1763067553000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Outcomes of Esophageal Cancer in Malawi: An Analysis of Overall Survival and Patient-Reported Outcomes"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8367-0779","authenticated-orcid":true,"given":"Gift","family":"Mulima","sequence":"first","affiliation":[{"name":"Kamuzu Central Hospital, Lilongwe, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0218-6948","authenticated-orcid":true,"given":"Gita N.","family":"Mody","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bongani","family":"Kaimila","sequence":"additional","affiliation":[{"name":"UNC-Project Malawi, Lilongwe, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ande","family":"Salima","sequence":"additional","affiliation":[{"name":"UNC-Project Malawi, Lilongwe, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1543-6195","authenticated-orcid":true,"given":"Brittney","family":"Williams","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-882X","authenticated-orcid":true,"given":"Alan","family":"Paciorek","sequence":"additional","affiliation":[{"name":"UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA"},{"name":"Division of Hematology\/Oncology, University of California, San Francisco, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Charles","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate D.","family":"Westmoreland","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill, NC"},{"name":"UNC-Project Malawi, Lilongwe, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9705-4114","authenticated-orcid":true,"given":"Katherine","family":"Van Loon","sequence":"additional","affiliation":[{"name":"UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA"},{"name":"Division of Hematology\/Oncology, University of California, San Francisco, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-0397","authenticated-orcid":true,"given":"Geoffrey C.","family":"Buckle","sequence":"additional","affiliation":[{"name":"UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA"},{"name":"Division of Hematology\/Oncology, University of California, San Francisco, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.01.001"},{"key":"e_1_3_8_4_2","article-title":"Improving access to self-expanding metal stents for patients with esophageal cancer in Eastern Africa: A stepwise implementation strategy","author":"Mushi BP","unstructured":"Mushi BP, Mwachiro MM, Buckle G, et al: Improving access to self-expanding metal stents for patients with esophageal cancer in Eastern Africa: A stepwise implementation strategy. JCO Glob Oncol 10.1200\/GO.20.00318","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33299"},{"key":"e_1_3_8_6_2","article-title":"Characteristics of esophageal cancer cases in Tanzania","author":"Mmbaga E","unstructured":"Mmbaga E, Deardorff KV, Merritt M, et al: Characteristics of esophageal cancer cases in Tanzania. JCO Glob Oncol 10.1200\/JGO.2016.006619","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.4314\/eamj.v78i12.8935"},{"key":"e_1_3_8_8_2","first-page":"147","article-title":"The surgical management and outcome of oesophageal cancer in Addis Ababa","volume":"38","author":"Ahmed AA","year":"2000","unstructured":"Ahmed AA: The surgical management and outcome of oesophageal cancer in Addis Ababa. Ethiop Med J 38:147-152, 2000","journal-title":"Ethiop Med J"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014080"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70004-X"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(01)70415-4"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23003"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000333"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12522"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.10.004"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09124-5"},{"key":"e_1_3_8_17_2","article-title":"The African esophageal cancer consortium: A call to action","author":"Van Loon K","unstructured":"Van Loon K, Mwachiro MM, Abnet CC, et al: The African esophageal cancer consortium: A call to action. JCO Glob Oncol 10.1200\/JGO.17.00163","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_8_18_2","volume-title":"11th International Conference on Cancer in Africa: AORTIC","author":"Van Loon K","year":"2017","unstructured":"Van Loon K, Mmbaga E, Mushi B, et al: Molecular determinants of esophageal cancer in Tanzania, in 11th International Conference on Cancer in Africa: AORTIC. Kigali, Rwanda, 2017"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2010.09.001"},{"key":"e_1_3_8_20_2","first-page":"CD004063","article-title":"Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer","volume":"11","author":"Janmaat VT","year":"2017","unstructured":"Janmaat VT, Steyerberg EW, van der Gaast A, et al: Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database Syst Rev 11:CD004063, 2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_8_21_2","first-page":"CD005048","article-title":"Interventions for dysphagia in oesophageal cancer","volume":"2014","author":"Dai Y","year":"2014","unstructured":"Dai Y, Li C, Xie Y, et al: Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 2014:CD005048, 2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00720-8"},{"key":"e_1_3_8_23_2","article-title":"Survival after diagnosis of esophageal squamous cell carcinoma in Malawi","author":"Kaimila B","unstructured":"Kaimila B, Chen Y, Mulima G, et al: Survival after diagnosis of esophageal squamous cell carcinoma in Malawi. JCO Glob Oncol 10.1200\/GO.23.00173","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_8_24_2","first-page":"66","article-title":"Development and internal validation of the survival time risk score in patients treated for oesophageal cancer with palliative intent in South Africa","volume":"61","author":"Ferndale L","year":"2023","unstructured":"Ferndale L, Ayeni O, Chen W, et al: Development and internal validation of the survival time risk score in patients treated for oesophageal cancer with palliative intent in South Africa. S Afr J Surg 61:66-74, 2023","journal-title":"S Afr J Surg"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezv135"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLE.0000000000000332"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T20:59:20Z","timestamp":1763067560000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1200\/GO-25-00221"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00221","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"2025-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500221"}}